Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.1.2 (
glutamate dehydrogenase
)
4,380
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acinetobacter lwoffii strain ISP4 metabolizes isophthalate rapidly compared with Pseudomonas aeruginosa strain PP4 and Pseudomonas strain
PPD
. Isophthalate has been reported to be a potent competitive inhibitor of
glutamate dehydrogenase
(
GDH
). Exogenous supplementation of isophthalate with glutamate or alpha-ketoglutarate at 1 mM concentration caused strains PP4 and
PPD
to grow faster than in the presence of isophthalate alone; however, no such effect was observed in strain ISP4. When grown on isophthalate, all strains showed activity of NADP-dependent
GDH
(NADP-GDH), while cells grown on glucose, 2x yeast extract-tryptone broth (2YT) or glutamate showed activities of both NAD-dependent
GDH
(NAD-GDH) and NADP-
GDH
. Activity staining, inhibition and thermal stability studies indicated the carbon source-dependent presence of two (
GDH
(I) and
GDH
(II)), three (
GDH
(A),
GDH
(B) and
GDH
(C)) and one (
GDH
(P)) forms of NADP-
GDH
in strains PP4,
PPD
and ISP4, respectively. The results demonstrate the carbon source-dependent modulation of different forms of NADP-
GDH
in these bacterial strains. This modulation may help the efficient utilization of isophthalate as a carbon source by overcoming the inhibitory effect on
GDH
.
...
PMID:Carbon source-dependent modulation of NADP-glutamate dehydrogenases in isophthalate-degrading Pseudomonas aeruginosa strain PP4, Pseudomonas strain PPD and Acinetobacter lwoffii strain ISP4. 1895 86